CN100333778C - Natural life beneficial Chinese medicine - Google Patents
Natural life beneficial Chinese medicine Download PDFInfo
- Publication number
- CN100333778C CN100333778C CNB2004100986799A CN200410098679A CN100333778C CN 100333778 C CN100333778 C CN 100333778C CN B2004100986799 A CNB2004100986799 A CN B2004100986799A CN 200410098679 A CN200410098679 A CN 200410098679A CN 100333778 C CN100333778 C CN 100333778C
- Authority
- CN
- China
- Prior art keywords
- shares
- radix
- root
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a natural life beneficial Chinese medicine, the prescription of which comprises: astragalus root, kelp, Chinese angelica root, ginseng, oldenlandia, rabdosia, barbat skullcap, spica prunellae, glossy privet fruit, lily, tuckahoe, white atractylodes rhizome, stemona root, seaweeds, turtle shell, wall gecko, licorice root, xanthium, agrimony, giant knotweed rhizome and bupleurum root. The prescription of the Chinese medicine has the weight parts for each component: 20 to 50 shares of the astragalus root, 10 to 20 shares of the kelp, 12 to 20 shares of the Chinese angelica root, 15 to 30 shares of the ginseng, 30 to 50 shares of the oldenlandia, 12 to 30 shares of the rabdosia, 20 to 50 shares of the barbat skullcap, 10 to 30 shares of the spica prunellae, 10 to 20 shares of the glossy privet fruit, 10 to 20 shares of the lily, 12 to 30 shares of the tuckahoe, 12 to 20 shares of the white atractylodes rhizome, 10 to 20 shares of the stemona root, 12 to 30 shares of the seaweed, 20 to 50 shares of the turtle shell, 20 to 50 shares of the wall gecko, 10 to 15 shares of the licorice root, 12 to 20 shares of the xanthium, 12 to 60 shares of the agrimony, 12 to 40 shares of the giant knotweed rhizome, and 10 to 40 shares of the bupleurum root. The natural life beneficial Chinese medicine of the present invention can totally have curative effects on carcinoma of maxillary sinus, liver cancer, lung cancer, uterine cancer, etc. by clinical practice, and the long-term take of the present invention does not have toxicity, side effects and medicine resistance.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of cancer.
Background technology
This year, air pollution aggravation, pesticide residues, soil chemical contamination are serious day by day, and various malignancy of tumor are the target of criticism and are increased gradually.The Chinese for thousands of years traditional Chinese medical science performs deeds of valour in battle at the prophylactic treatment various diseases.Chinese traditional treatment does not only have the side effect of western medical treatment, radiotherapy, chemotherapy, and takes the reinforcement and elimination in combination debate to execute and control, and with disease plus-minus inrigorating qi and promoting blood circulation, kill cancer cell increases the normal cell resistance, strengthens general immunity power.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine for the treatment of cancer, to reach anti-cancer, to treat the effect that cancer lengthens one's life.
The Chinese medicine of treatment cancer of the present invention, it is characterized in that, form: Radix Astragali 20-50, Thallus Laminariae (Thallus Eckloniae) 10-20, Radix Angelicae Sinensis 12-20, Radix Ginseng 15-30, Herba Hedyotidis Diffusae 30-50, Rabdosia rubescens 12-30, Herba Scutellariae Barbatae 20-50, Spica Prunellae 10-30, Fructus Ligustri Lucidi 10-20, Bulbus Lilii 10-20, Poria 12-30, Rhizoma Atractylodis Macrocephalae 12-20, Radix Stemonae 10-20, Sargassum 12-30, Carapax Trionycis 20-50, Gekko Swinhonis 20-50, Radix Glycyrrhizae 10-15, Fructus Xanthii 12-20, Herba Agrimoniae 12-60, Rhizoma Polygoni Cuspidati 12-40, Radix Bupleuri 10-40 by the raw material of following weight portion.
This Chinese medicine compound method: earlier each component is cleaned up, oven dry, levigation, capsule is made in sterilization.
The instructions of taking of Chinese medicine of the present invention: one time 5, three times on the one; One month one course of treatment.
The effect of each component is as follows in the Chinese medicine of treatment cancer of the present invention:
Radix Ginseng, Radix Astragali tonifying QI to promote blood circulation, Chinese angelica blood supplementing is invigorated blood circulation, Rabdosia rubescens, Herba Scutellariae Barbatae, the antiinflammatory of Herba Hedyotidis Diffusae heat-clearing and toxic substances removing, Gekko Swinhonis, Carapax Trionycis, Thallus Laminariae (Thallus Eckloniae), Sargassum drastically removing blood stasis and resolving static blood, Radix Bupleuri, the Radix Stemonae, the Bulbus Lilii the chest stuffiness relieving of regulating the flow of vital energy, Poria, Rhizoma Polygoni Cuspidati eliminating dampness and diuresis strengthen body immunity, the Herba Agrimoniae hemostasis is anticancer, the collaborative tonifying QI to promote blood circulation of all medicines is enriched blood up tap holder face, descending lower abdomen, broken knot dissipating blood stasis is comprehensively controlled cancerous protuberance.
Through clinical practice, carcinoma of maxillary sinus, hepatocarcinoma, pulmonary carcinoma, uterus carcinoma etc. are taken all sxs, take first quarter moon obviously to alleviate, and cure in 1 year to 2 years, and effective percentage is more than 90%, cure rate 46%, and take for a long time and have no side effect, have no drug resistance.
The specific embodiment
In one embodiment of the invention, the Chinese medicine of treatment cancer of the present invention, each raw materials in part by weight is: the Radix Astragali 20, Thallus Laminariae (Thallus Eckloniae) 10, Radix Angelicae Sinensis 12, Radix Ginseng 15, Herba Hedyotidis Diffusae 30, Rabdosia rubescens 12, Herba Scutellariae Barbatae 20, Spica Prunellae 10, Fructus Ligustri Lucidi 10, Bulbus Lilii 10, Poria 12, the Rhizoma Atractylodis Macrocephalae 12, the Radix Stemonae 10, Sargassum 12, Carapax Trionycis 20, Gekko Swinhonis 20, Radix Glycyrrhizae 10, Fructus Xanthii 12, Herba Agrimoniae 12, Rhizoma Polygoni Cuspidati 12, Radix Bupleuri 10
In another embodiment of the present invention, the Chinese medicine of treatment cancer of the present invention, each raw materials in part by weight is: the Radix Astragali 50, Thallus Laminariae (Thallus Eckloniae) 20, Radix Angelicae Sinensis 20, Radix Ginseng 30, Herba Hedyotidis Diffusae 50, Rabdosia rubescens 30, Herba Scutellariae Barbatae 50, Spica Prunellae 30, Fructus Ligustri Lucidi 20, Bulbus Lilii 10, Poria 30, the Rhizoma Atractylodis Macrocephalae 20, the Radix Stemonae 10, Sargassum 30, Carapax Trionycis 50, Gekko Swinhonis 20, Radix Glycyrrhizae 15, Fructus Xanthii 20, Herba Agrimoniae 60, Rhizoma Polygoni Cuspidati 40, Radix Bupleuri 40.
In another embodiment of the present invention, the Chinese medicine of treatment cancer of the present invention, each raw materials in part by weight is: the Radix Astragali 35, Thallus Laminariae (Thallus Eckloniae) 15, Radix Angelicae Sinensis 16, Radix Ginseng 20, Herba Hedyotidis Diffusae 40, Rabdosia rubescens 20, Herba Scutellariae Barbatae 35, Spica Prunellae 20, Fructus Ligustri Lucidi 15, Bulbus Lilii 15, Poria 25, the Rhizoma Atractylodis Macrocephalae 15, the Radix Stemonae 15, Sargassum 20, Carapax Trionycis 35, Gekko Swinhonis 30, Radix Glycyrrhizae 12, Fructus Xanthii 16, Herba Agrimoniae 35, Rhizoma Polygoni Cuspidati 25, Radix Bupleuri 25.
Capsule is made: clean up oven dry medicine-feeding levigation, sterilization, aseptic encapsulated; Oral: each 5, three times on the one, one month one course of treatment.
Cure mainly: carcinoma of maxillary sinus, hepatocarcinoma, pulmonary carcinoma, uterus carcinoma etc. are all effective in cure, and take for a long time and have no side effect, and have no drug resistance.
Curative effect: carcinoma of maxillary sinus, hepatocarcinoma, pulmonary carcinoma, uterus carcinoma etc. are taken all sxs, take first quarter moon obviously to alleviate, and cure in 1 year to 2 years, and effective percentage is more than 90%, cure rate 46%.
Clinical trial:
Case 1:
The Meng big gun, man, 26 years old, do not heal for a long time because of suffering from rhinitis 6 years in March, 92, is carcinoma of maxillary sinus through the true disease of the sick inspection of Henan Province's tumor medicine CT, through chemotherapy, radiotherapy, March maxillary sinus fester, upper jaw bone is the bean curd slag specimen, hemorrhagely more is not critically ill.
Prescription: the Radix Astragali 20, Thallus Laminariae (Thallus Eckloniae) 10, Radix Angelicae Sinensis 12, Radix Ginseng 15, Herba Hedyotidis Diffusae 30, Rabdosia rubescens 12, Herba Scutellariae Barbatae 20, Spica Prunellae 10, Fructus Ligustri Lucidi 10, Bulbus Lilii 10, Poria 12, the Rhizoma Atractylodis Macrocephalae 12, the Radix Stemonae 10, Sargassum 12, Carapax Trionycis 20, Gekko Swinhonis 20, Radix Glycyrrhizae 10, Fructus Xanthii 12, Herba Agrimoniae 12, Rhizoma Polygoni Cuspidati 12, Radix Bupleuri 10.
Compound method: earlier each component is cleaned up, oven dry, levigation, capsule is made in sterilization.
Instructions of taking: one time 5, three times on the one.
Curative effect: adhere to taking half a year, cure.
Case 2:
Ye Rong, the woman, 32 years old, four buildings, Tongxu people from Zhang village was diagnosed as hepatitis B on April 6th, 91, do not heal in 6 years, hepatalgia increases the weight of, and jaundice occurs, emaciation and sallow complexion, can lay one's hand under the liver rib and following 2 centimetres of rib, tenderness is kowtowed the slight ascites of pain, through Henan Province hospitalize not good enough, go to this hospitalize.
Treatment prescription: the Radix Astragali 50, Thallus Laminariae (Thallus Eckloniae) 20, Radix Angelicae Sinensis 20, Radix Ginseng 30, Herba Hedyotidis Diffusae 50, Rabdosia rubescens 30, Herba Scutellariae Barbatae 50, Spica Prunellae 30, Fructus Ligustri Lucidi 20, Bulbus Lilii 10, Poria 30, the Rhizoma Atractylodis Macrocephalae 20, the Radix Stemonae 10, Sargassum 30, Carapax Trionycis 50, Gekko Swinhonis 20, Radix Glycyrrhizae 15, Fructus Xanthii 20, Herba Agrimoniae 60, Rhizoma Polygoni Cuspidati 40, Radix Bupleuri 40.
Compound method: earlier each component is cleaned up, oven dry, levigation, capsule is made in sterilization.
Instructions of taking: one time 5, three times on the one.
Curative effect: through taking Chinese medicine August, jaundice disappears, pain relief, the basic healing.
Case 3:
Sun Jun, the man, 46 years old, hilllock people from village erected in the Tongxu, suffered from pulmonary carcinoma, and the present is cough always over the past half year, and the expectorant insufficiency of blood is many, shows through CT examination and goes up leaf cavity type shade in two lungs, and expectorant disorders of blood reason has a large amount of lung gland type cancerous cell, goes to this hospitalize.Treatment prescription: the Radix Astragali 35, Thallus Laminariae (Thallus Eckloniae) 15, Radix Angelicae Sinensis 16, Radix Ginseng 20, Herba Hedyotidis Diffusae 40, Rabdosia rubescens 20, Herba Scutellariae Barbatae 35, Spica Prunellae 20, Fructus Ligustri Lucidi 15, Bulbus Lilii 15, Poria 25, the Rhizoma Atractylodis Macrocephalae 15, the Radix Stemonae 15, Sargassum 20, Carapax Trionycis 35, Gekko Swinhonis 30, Radix Glycyrrhizae 12, Fructus Xanthii 16, Herba Agrimoniae 35, Rhizoma Polygoni Cuspidati 25, Radix Bupleuri 25.
Compound method: earlier each component is cleaned up, oven dry, levigation, capsule is made in sterilization.
Instructions of taking: one time 5, three times on the one.
Curative effect: through taking Chinese medicine June, sx continues to take after the back family after 9 months and cures.
Claims (2)
1, a kind of Chinese medicine for the treatment of cancer, it is characterized in that, form: Radix Astragali 20-50, Thallus Laminariae (Thallus Eckloniae) 10-20, Radix Angelicae Sinensis 12-20, Radix Ginseng 15-30, Herba Hedyotidis Diffusae 30-50, Rabdosia rubescens 12-30, Herba Scutellariae Barbatae 20-50, Spica Prunellae 10-30, Fructus Ligustri Lucidi 10-20, Bulbus Lilii 10-20, Poria 12-30, Rhizoma Atractylodis Macrocephalae 12-20, Radix Stemonae 10-20, Sargassum 12-30, Carapax Trionycis 20-50, Gekko Swinhonis 20-50, Radix Glycyrrhizae 10-15, Fructus Xanthii 12-20, Herba Agrimoniae 12-60, Rhizoma Polygoni Cuspidati 12-40, Radix Bupleuri 10-40 by the raw material of following weight portion.
2, the Chinese medicine of treatment cancer as claimed in claim 1, it is characterized in that each raw materials in part by weight is in this Chinese medicine: the Radix Astragali 20, Thallus Laminariae (Thallus Eckloniae) 10, Radix Angelicae Sinensis 12, Radix Ginseng 15, Herba Hedyotidis Diffusae 30, Rabdosia rubescens 12, Herba Scutellariae Barbatae 20, Spica Prunellae 10, Fructus Ligustri Lucidi 10, Bulbus Lilii 10, Poria 12, the Rhizoma Atractylodis Macrocephalae 12, the Radix Stemonae 10, Sargassum 12, Carapax Trionycis 20, Gekko Swinhonis 20, Radix Glycyrrhizae 10, Fructus Xanthii 12, Herba Agrimoniae 12, Rhizoma Polygoni Cuspidati 12, Radix Bupleuri 10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100986799A CN100333778C (en) | 2004-12-16 | 2004-12-16 | Natural life beneficial Chinese medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100986799A CN100333778C (en) | 2004-12-16 | 2004-12-16 | Natural life beneficial Chinese medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1651055A CN1651055A (en) | 2005-08-10 |
CN100333778C true CN100333778C (en) | 2007-08-29 |
Family
ID=34869522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100986799A Expired - Fee Related CN100333778C (en) | 2004-12-16 | 2004-12-16 | Natural life beneficial Chinese medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100333778C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101791343B (en) * | 2010-03-23 | 2011-12-07 | 杜建 | Traditional Chinese medicine for treating tumor of digestive tract, strengthening body resistance and removing summer-heat |
CN104800538A (en) * | 2015-05-14 | 2015-07-29 | 奉化科创科技服务有限公司 | Traditional Chinese medicine for treating lung cancer |
CN107823296A (en) * | 2017-12-01 | 2018-03-23 | 贵州健瑞安药业有限公司 | A kind of pedicure prescription for the treatment of cancer and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1232682A (en) * | 1998-04-20 | 1999-10-27 | 贾冶 | Chinese medicine for curing malignant tumor and its preparation |
-
2004
- 2004-12-16 CN CNB2004100986799A patent/CN100333778C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1232682A (en) * | 1998-04-20 | 1999-10-27 | 贾冶 | Chinese medicine for curing malignant tumor and its preparation |
Non-Patent Citations (1)
Title |
---|
抗癌中草药的研究进展 邓士贤,云南医药,第6卷第1期 1985 * |
Also Published As
Publication number | Publication date |
---|---|
CN1651055A (en) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101129552A (en) | Traditional Chinese medicine for treating chronic functional constipation | |
CN101380386A (en) | Traditional Chinese medicine composition for tonifying the kidney yang | |
CN101152535A (en) | Traditional Chinese medicine for treating subacute thyroiditis | |
CN101152539A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
CN103272096A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
CN101129945A (en) | Traditional Chinese medicine for treating diffuse liver cancer | |
CN101129617A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN102579753A (en) | Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery | |
CN101129966A (en) | Traditional Chinese medicine for treating hyperthyroidism accompanied by diarrhea | |
CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
CN101129970A (en) | Traditional Chinese medicine for treating middle and late stage liver cancer | |
CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
CN100333778C (en) | Natural life beneficial Chinese medicine | |
CN101152540A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN106075265A (en) | The Chinese medicine composition for the treatment of viral influenza | |
CN101703645B (en) | Chinese medicinal composition for treating cervical vertebra hyperosteogeny | |
CN101732622A (en) | Chinese medicament for treating ischidrosis | |
CN101167828A (en) | Traditional Chinese medicine for treating acute bacillary dysentery | |
CN105597030A (en) | Traditional Chinese medicine composition with functions of dispersing blood stasis and dredging vessels | |
CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
CN104225202A (en) | Traditional Chinese medicine prescription for treating lung cancer | |
CN102397403A (en) | Medicine for treating kidney dysfunction | |
CN101152394A (en) | Traditional Chinese medicine for treating chronic active hepatitis | |
CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070829 Termination date: 20100118 |